Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies
L
Lior Z. Braunstein
(Memorial Sloan Kettering Cancer Center, New York, NY)
M
Melissa P. Mitchell
(The University of Texas MD Anderson Cancer Center, Houston, TX)
A
Atif J. Khan
(Memorial Sloan Kettering Cancer Center, New York)
W
William M. Sikov
(Women and Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, RI)
E
Eleftherios P. Mamounas
(AdventHealth Cancer Institute, Orlando, FL)
T
Thomas B. Julian
(Allegheny Health Network Cancer Institute, Pittsburgh)
N
Norman Wolmark
(University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 1, Issue 1
Published
June 08, 2026
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (7)
L
Lior Z. Braunstein
Memorial Sloan Kettering Cancer Center, New York, NY
M
Melissa P. Mitchell
The University of Texas MD Anderson Cancer Center, Houston, TX
A
Atif J. Khan
Memorial Sloan Kettering Cancer Center, New York
W
William M. Sikov
Women and Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, RI
E
Eleftherios P. Mamounas
AdventHealth Cancer Institute, Orlando, FL
T
Thomas B. Julian
Allegheny Health Network Cancer Institute, Pittsburgh
N
Norman Wolmark
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001